Financial Effects of Pharmaceutical Price Regulation on R&D Spending by EU versus US Firms

被引:0
|
作者
Joseph Golec
John A. Vernon
机构
[1] University of Connecticut,Finance Department, School of Business
[2] University of North Carolina at Chapel Hill,Department of Health Policy and Management
[3] National Bureau of Economic Research (NBER),undefined
来源
PharmacoEconomics | 2010年 / 28卷
关键词
Stock Return; Price Regulation; Price Control; Price Inflation; Pharmaceutical Firm;
D O I
暂无
中图分类号
学科分类号
摘要
EU countries closely regulate pharmaceutical prices, whereas theUS does not.
引用
收藏
页码:615 / 628
页数:13
相关论文
共 50 条